Nrf2-Mediated Dichotomy in the Vascular System: Mechanistic and Therapeutic Perspective

Area of Science:

• Cardiovascular Biology
• Molecular Medicine
• Transcription Factor Regulation

Background:

• Nuclear factor-erythroid 2-related factor 2 (Nrf2) is a master regulator of cellular defense mechanisms, controlling over 1000 genes involved in redox balance, metabolism, and protein quality control.
• While Nrf2 is primarily recognized for its protective antioxidant functions in the cardiovascular system, emerging research highlights its context-dependent detrimental roles.

Purpose of the Study:

• To review the multifaceted role of Nrf2 in cardiovascular diseases, with a specific emphasis on its impact on vascular disease.
• To elucidate the negative effects of Nrf2 on the vasculature and explore the underlying molecular mechanisms.
• To discuss the clinical implications of targeting Nrf2 pathways for therapeutic interventions in cardiovascular and other diseases.

Main Methods:

• Literature review of existing studies on Nrf2 in cardiovascular diseases.
• Analysis of research focusing on Nrf2's role in vascular dysfunction.
• Synthesis of evidence regarding the mechanisms of Nrf2-mediated cardiovascular effects.

Main Results:

• Nrf2 activation can exert both protective and detrimental effects on the cardiovascular system.
• Emerging evidence indicates a significant negative impact of Nrf2 on vascular health and function in specific disease contexts.
• Potential mechanisms for Nrf2's detrimental vascular effects are being identified.

Conclusions:

• Nrf2's role in cardiovascular disease is complex and context-dependent, extending beyond its known antioxidant functions.
• Targeting Nrf2 pathways presents a potential therapeutic strategy for cardiovascular diseases, but requires careful consideration of its dual nature.
• Further research is needed to fully understand and leverage Nrf2 modulation for clinical benefit.